Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
Search Article 
Advanced search 
  Users Online: 1934 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
This article has been cited by
1Combination therapy of sodium–glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors in type 2 diabetes: rationale and evidences
Awadhesh Kumar Singh,Ritu Singh
Expert Review of Clinical Pharmacology.2016;9(2)229
2Sodium glucose CoTransporter 2 (SGLT2) inhibitors: Current status and future perspective
Tushar Madaan,Mohd. Akhtar,Abul Kalam Najmi
European Journal of Pharmaceutical Sciences.2016;93(2)244
3SGLT2 Inhibitors and Ketoacidosis: Pathophysiology and Management
Yun Hyi Ku
The Korean Journal of Medicine.2017;92(5)443
4Sodium-glucose co-transporter-2 inhibitors and the risk of ketoacidosis in patients with type 2 diabetes mellitus: A nationwide population-based cohort study
Young-Gun Kim,Ja Young Jeon,Seung Jin Han,Dae Jung Kim,Kwan-Woo Lee,Hae Jin Kim
Diabetes, Obesity and Metabolism.2018;20(8)1852
5Sodium-glucose co-transporter type-2 inhibitors: pharmacology and peri-operative considerations
D. A. Milder,T. Y. Milder,P. C. A. Kam
6Spotlight on Canagliflozin 300: review of its efficacy and an indirect comparison to other SGLT-2 inhibitors and long-acting GLP-1 receptor agonists
Awadhesh Kumar Singh,Ritu Singh
Expert Review of Clinical Pharmacology.2017;10(6)633
7Postoperative Euglycaemic Diabetic Ketoacidosis Associated with Sodium–Glucose Cotransporter-2 Inhibitors (Gliflozins): A Report of Two Cases and Review of the Literature
B. Chacko,M. Whitley,U. Beckmann,K. Murray,M. Rowley
Anaesthesia and Intensive Care.2018;46(2)215
8Euglycemic diabetic ketoacidosis in type 2 diabetes with sodium glucose cotransporter 2 inhibitors
An-Yi Wang,Sen-Kuang Hou,Shan-Jen Li,Wei-Fong Kao
The American Journal of Emergency Medicine.2017;35(2)379.e5
9Cardiac arrest from acute myocardial infarction complicated with sodium-glucose cotransporter 2 inhibitor-associated ketoacidosis
Zhehao Dai,Yosuke Nishihata,Naoto Kawamatsu,Ikki Komatsu,Atsushi Mizuno,Masato Shimizu,Nozomi Toya,Shinichi Ishimatsu,Nobuyuki Komiyama
Journal of Cardiology Cases.2017;15(2)56
10Pharmacokinetic and pharmacodynamic drug evaluation of tofogliflozin for the treatment of type 2 diabetes
Kalliopi Pafili,Efstratios Maltezos,Nikolaos Papanas
Expert Opinion on Drug Metabolism & Toxicology.2016;12(11)1367
11Diabetic ketoacidosis, sodium glucose transporter-2 inhibitors and the kidney
Biff F. Palmer,Deborah J. Clegg,Simeon I. Taylor,Matthew R. Weir
Journal of Diabetes and its Complications.2016;30(6)1162
12SGLT2 Inhibitor–associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis
Ronald M. Goldenberg,Lori D. Berard,Alice Y.Y. Cheng,Jeremy D. Gilbert,Subodh Verma,Vincent C. Woo,Jean-François Yale
Clinical Therapeutics.2016;38(12)2654
13Perfil clínico de los pacientes con diabetes mellitus tipo 2 tratados con inhibidores del cotransportador sodio-glucosa tipo 2 y experiencia clínica real en España
Gabriel Cuatrecasas,Fernando Goñi-Goicoechea
Medicina Clínica.2016;147(12)30
14Hyperglycemic Emergencies in Adults
Jeannette Goguen,Jeremy Gilbert
Canadian Journal of Diabetes.2018;42(12)S109
15Sodium-glucose co-transporter-2 inhibitors and diabetic ketoacidosis: A n updated review of the literature
Benedetta Maria Bonora,Angelo Avogaro,Gian Paolo Fadini
Diabetes, Obesity and Metabolism.2018;20(1)25
16Risk of Euglycemic Diabetic Ketoacidosis Due to Low-carbohydrate Diet While Taking Empagliflozin: a Case Report
Mariko Yamamoto,Naohito Ide,Shinzo Kitajima,Masakazu Obayashi,Kei Asada,Satoru Matsushima,Masaharu Ito
YAKUGAKU ZASSHI.2019;139(11)1479

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal